Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-009536)

Filing Details

Accession Number:: 0001415889-24-009536
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-04-01 16:34:52
Reporting Period:: 2024-03-28

Accepted Time:: 2024-04-01 16:34:52
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1597264	Blueprint Medicines Corp	BPMC	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1651036	Michael Landsittel	C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139	Chief Financial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2024-03-28	5,000	$36.05	52,286	No	4	M	Direct
Common Stock	Disposition	2024-03-28	5,000	$95.00	47,286	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2024-03-28	5,000	$0.00	5,000	$36.05

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
10,000		2027-02-16	No	4	M	Direct

Footnotes

Effected through a trading plan adopted on December 6, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This option was granted on February 16, 2017 and is fully vested as of the transaction date.